European Commission approves the commercialization of the novel estetrol and drospirenone containing oral contraceptive
20/05/2021
Business related granted Marketing authorization application PARTNER - MITHRA PRODUCT - DROVELIS Regulatory
244 kb 20/05/2021 pdf